Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Financial statements and analysis
Period names from company filings, with term end dates and filing dates
Income Statement (USD) Term End Date Filing Date | 2025 Dec 31, 2025 Mar 26, 2026 | 2024 Dec 31, 2024 Mar 26, 2026 |
|---|
Total Revenue | - | - |
Cost of Revenue | - | - |
Gross Profit | - | - |
Gross Margin % | - | - |
Research & Development | 138.35M 101.9% | 68.52M |
General & Administrative | 30.73M 113.1% | 14.42M |
Selling & Marketing | - | - |
SG&A Expenses | - | - |
Other Operating Expenses | - | - |
Total Operating Expenses | 169.08M 103.8% | 82.95M |
Cost and Expenses | - | - |
Operating Income | -169.08M 103.8% | -82.95M |
Operating Margin % | - | - |
EBITDA | - | - |
EBITDA Margin % | - | - |
Interest Expense | - | - |
Interest Income | 5.52M 22.5% | 4.50M |
Other Income (Expense) | - | - |
Pre-Tax Income | - | - |
Pre-Tax Margin % | - | - |
Tax Provision | - | - |
Net Income | -161.15M 107.7% | -77.58M |
Net Margin % | - | - |
Basic EPS | -18.56 82.4% | -105.38 |
Diluted EPS | -18.56 82.4% | -105.38 |
Basic Shares Outstanding | 8.68M 1079.2% | 736.18K |
Diluted Shares Outstanding | 8.68M 1079.2% | 736.18K |